Those stages help determine treatment, and they also reflect a patient’s prognosis. Experts say hypertrophic cardiomyopathy ...

Hypertrophic Cardiomyopathy Program, Division of Cardiology, Toronto General Hospital; Department of Medicine, University of Toronto,Toronto, ON Anthony Ralph-Edwards, MD, FRCSC, Division of ...

A study has found that aficamten is associated with improvements across a range of clinical outcomes in patients with obstructive hypertrophic cardiomyopathy.

If 1 in 500 Americans have hypertrophic cardiomyopathy, why isn’t it more talked about? The HCMA hopes to change that by upending common misconceptions.

Rolling Submission of NDA for Aficamten Completed and Submitted to FDA in Q3 COMET-HF, Confirmatory Phase 3 Clinical Trial of ...

In a remarkable display of expertise and advanced cardiac care, KMC Hospital, Dr B R Ambedkar Circle successfully treated Fr Wolfgang Leonhard, a 65-year-old German national, who was rushed to the ...

Hypertrophic cardiomyopathy (HCM ... and the most appropriate investigations for persons suspected of having HCM. Treatment strategies for the disease and its complications are presented briefly.

Hypertrophic cardiomyopathy (HCM ... The primary goals of treatment for HCM are to manage symptoms, halt or slow down the ...